• Corpus ID: 38288605

Clinical Trials with Thiamine Tetrahydrofurfuryl Disulfide ( TTFD ) in Down ' s Syndrome

  title={Clinical Trials with Thiamine Tetrahydrofurfuryl Disulfide ( TTFD ) in Down ' s Syndrome},
  author={Derrick Lonsdale and C. Kissling},
A clinical trial with megadose vitamin supplements reported benefit in some children with Down's syndrome. Since that time at least one study of a similar nature was reported to show no effect. However, this study did not follow the same protocol as Harrell and Associates, since no thyroid was administered. Thiamine tetrahydrofurfuryl disulfide (TTFD), a synthetic allithiamine, has been shown to have some therapeutic effects which strongly suggest that it enhances the physiologic actions of… 
4 Citations

Tables from this paper

A Review of the Biochemistry, Metabolism and Clinical Benefits of Thiamin(e) and Its Derivatives
  • D. Lonsdale
  • Medicine
    Evidence-based complementary and alternative medicine : eCAM
  • 2006
This paper refers to the previously described symptomatology of beriberi, emphasizing that it differs from that in pure, experimentally induced thiamine deficiency in human subjects, and emphasis is placed on the fact that ingestion of excessive simple carbohydrates automatically increases the need for this vitamin.
Complementary and alternative therapies for Down syndrome.
  • N. Roizen
  • Medicine, Psychology
    Mental retardation and developmental disabilities research reviews
  • 2005
There is a lack of well-designed scientific studies on the use of alternative therapies in individuals with Down syndrome, but antioxidants hold theoretical promise for treatment of the cognitive, immune, malignancy, and premature aging problems associated with Down Syndrome.
Clinical trials in children with Down syndrome: Issues from a cognitive research perspective
The history of clinical trial research in children with DS from a cognitive research perspective is reviewed and important issues relevant to the conduct of well designed clinical trials for this population are discussed.
Pharmacological interventions to improve cognition and adaptive functioning in Down syndrome: Strides to date
The progression from pre‐clinical studies with mouse models to human clinical trials research using pharmacological interventions to improve cognition and adaptive functioning in Down syndrome is described.


Down ' s Syndrome and Thiamine Deficiency
A hypothesis suggesting maternal thiamine deficiency as a possible cause of Down's Syndrome (and trisomy 21 of bone marrowpreleukemia) is outlined and primary, secondary, and tertiary prevention of down's Syndrome is discussed in the light of the findings and this hypothesis.
Effect of thiamine tetrahydrofurfuryl disulfide on audiogenic seizures in DBA/2J mice.
  • D. Lonsdale
  • Biology
    Developmental pharmacology and therapeutics
  • 1982
Evidence is presented that suggests that TTFD is cholinergic in its action and has pharmacologic effects other than a simple vitamin replacement and sex-related differences exist in their response to stress.
Absorption and passage of fat- and water-soluble thiamin derivatives into erythrocytes and cerebrospinal fluid of man.
Orally administered allithiamin vitamers are recommended for prophylaxis and treatment of thiamin deficits because they have the same biological properties as parenterally administered water-soluble thiamins.
The syndrome of functional dysautonomia.
Vitamin and mineral supplementation in Down's syndrome.
No support was found for the orthomolecular hypothesis in school-aged children with Down's syndrome, and no significant group differences or suggestive trends were found in any tested area of development or behavior.
Neurochemical studies of early-onset Alzheimer's disease. Possible influence on treatment.
Multiple neurotransmitter deficits found in recent autopsy studies of patients with Alzheimer's disease may militate against the success of "simple cholinergic replacement" as treatment. To study
On the mechanism of mental deficiency in chromosomal diseases.
Comparison with other diseases lead to the hypothesis that rather simple and localised mechanisms could be specially important in the production of chemical mediators.
Familial dysautonomia differentiated from related disorders. Case reports and discussions of current concepts.
It is apparent that the basic functional defect has not yet been identified, though a humoral anomaly, very possibly enzymatic, still seems a reasonable interpretation of the underlying cause of the physiological abnormalities reported.
Can nutritional supplements help mentally retarded children? an exploratory study.
The hypothesis that mental retardations are in part genetotrophic diseases requires an augmented supply of one or more nutrients such that when these nutrients are adequately supplied the disease is ameliorated is supported.
Down's syndrome in adults: brain metabolism.
Glucose utilization by the brain appears to be excessive in young adults with Down's syndrome but may decline with age in some brain regions.